Skip to main content

Table 1 Correlation between KAI1 and vimentin and E-cad expression to clinicopathological characteristics in 312 NSCLC patients

From: Clinicopathological significance of KAI1 expression and epithelial-mesenchymal transition in non-small cell lung cancer

Variable KAI1 P value E-cadherin P value Vimentin P value
(−) (+) (−) (+) (−) (+)
Ages    0.622    0.894    0.336
 <60 95 52   88 59   89 58  
 ≥60 111 54   100 65   91 74  
Gender    0.038    0.423    0.597
 Male 147 87   138 96   137 97  
 Female 59 19   50 28   43 35  
Diameter    0.081    0.070    0.368
 <3.0 cm 32 9   30 11   21 20  
 ≥3.0 cm 174 97   158 113   159 112  
Histology    0.283    0.077    0.323
 SCC 155 79   144 90   137 97  
 Adenocarcinoma 43 26   36 33   40 29  
 LCC 8 1   8 1   3 6  
Smoking    0.957    0.791    0.185
 Yes 151 78   139 90   127 102  
 No 55 28   49 34   53 30  
Grades of tumor    <0.001    <0.001    0.002
 Well 10 31   13 28   32 9  
 Moderately 135 68   116 87   118 85  
 Poorly 61 7   59 9   30 38  
TNM stages    <0.001    <0.001    <0.001
 I 10 57   7 60   65 2  
 II 85 35   77 43   89 31  
 III 111 14   104 21   26 99  
 VI    <0.001    <0.001    <0.001
 Yes 42 1   40 3   5 38  
 No 164 105   148 121   175 94  
Marginal free    0.119    0.085    <0.001
 Yes 171 95   155 111   167 99  
 No 35 11   33 13   13 33  
  1. NSCLC non-small cell lung cancer, SCC squamous cell carcinoma, LCC large cell carcinoma, VI vascular invasion